Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Diabetic Cardiomyopathies

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Diabetic Cardiomyopathies in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zhang, C1
Yu, H1
Yang, H1
Liu, B1
Zhang, H1
Xiong, Z1
Wang, J1
Zhang, S1
Lei, L1
Yang, L1
Zhang, Z1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Diabetic Cardiomyopathies

ArticleYear
Activation of PI3K/PKB/GSK-3β signaling by sciadopitysin protects cardiomyocytes against high glucose-induced oxidative stress and apoptosis.
    Journal of biochemical and molecular toxicology, 2021, Volume: 35, Issue:10

    Topics: Antioxidants; Apoptosis; Biflavonoids; Cell Line; Cell Survival; Chromones; Diabetic Cardiomyopathie

2021
Glucagon-like peptide-1 protects cardiomyocytes from advanced oxidation protein product-induced apoptosis via the PI3K/Akt/Bad signaling pathway.
    Molecular medicine reports, 2016, Volume: 13, Issue:2

    Topics: Advanced Oxidation Protein Products; Animals; Apoptosis; bcl-Associated Death Protein; Chromones; Di

2016